Product Information

PRAVASTATIN SODIUM 20 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0576 per EA under NDC 69097078905. Its NADAC has been published 99 times since Jan 1, 2025.

FDA first approved this application on May 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAVASTATIN SODIUM 20 MG TAB

PRAVASTATIN SODIUM
$0.0576per EA

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097078905

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PRAVASTATIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA077987

FDA Approved

5/11/2007

TE Code

AB

On Market Since

6/1/2024

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PRAVASTATIN SODIUM 20 MG TAB has been published 99 times since Jan 1, 2025, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0576 per EA
All-time high$0.0715 (Sep 10, 2025)
All-time low$0.0556 (Jan 1, 2025)
52-week high$0.0686
52-week low$0.0566
Median price$0.0642
Average price$0.0642
Largest weekly change+9.0% (Feb 19, 2025)
Weeks tracked99
Tracking sinceJan 1, 2025

Price History

1W

+1.9%

1M

-0.6%

3M

-7.1%

6M

-5.8%

1Y

-16.0%

3Y

N/A

5Y

N/A

All

+3.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAVASTATIN SODIUM 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 20 MG TAB, manufactured by Cipla USA Inc., is $0.0576 per EA (NDC 69097078905), effective Nov 18, 2026.

How has the price of PRAVASTATIN SODIUM 20 MG TAB changed over time?

Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has risen 3.5%. It has been tracked across 99 weekly CMS publications since Jan 1, 2025.

What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 20 MG TAB?

Since Jan 1, 2025, the NADAC for PRAVASTATIN SODIUM 20 MG TAB has ranged from a low of $0.0556 (Jan 1, 2025) to a high of $0.0715 (Sep 10, 2025), with a median of $0.0642 per EA.

Are there cheaper alternatives to PRAVASTATIN SODIUM 20 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAVASTATIN SODIUM 20 MG TAB, is $0.0519 per EA — about 10% below PRAVASTATIN SODIUM 20 MG TAB.

Who manufactures PRAVASTATIN SODIUM 20 MG TAB?

PRAVASTATIN SODIUM 20 MG TAB (NDC 69097078905) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.